Skip to main content
Erschienen in: Nuclear Medicine and Molecular Imaging 3/2024

18.01.2024 | Interesting image

Hepatic Superscan in Medullary Thyroid Carcinoma: A Rare Presentation in [18F]FDG PET/CT

verfasst von: Ahmed Saad Abdlkadir, Dhuha Al-Adhami, Baraa Alsyouf, Raghad Alhouwari, Ula Al-Rasheed, Omar Jaber, Issa Mohamad, Akram Al-Ibraheem

Erschienen in: Nuclear Medicine and Molecular Imaging | Ausgabe 3/2024

Einloggen, um Zugang zu erhalten

Excerpt

A 65-year-old female with longstanding goiter history and no familial cancer background exhibited intermittent right upper quadrant abdominal pain, nausea, vomiting, and greenish diarrhea. Recurrent dehydration prompted emergency visits, culminating in admission. Initial assessments indicated mild anemia and slightly elevated liver enzymes. In light of clinical presentation, an abdominal magnetic resonance imaging (MRI) revealed substantial hepatomegaly and liver lesions, prompting an ultrasound-guided liver biopsy to exclude malignancy. Pending results, the patient’s condition rapidly worsened, with intensified vomiting after each oral intake. …
Literatur
1.
Zurück zum Zitat Tamagnini P, Iacobone M, Sebag F, Marcy M, De Micco C, Henry J. Lymph node involvement in macroscopic medullary thyroid carcinoma. Br J Surg. 2005;92:449–53.CrossRefPubMed Tamagnini P, Iacobone M, Sebag F, Marcy M, De Micco C, Henry J. Lymph node involvement in macroscopic medullary thyroid carcinoma. Br J Surg. 2005;92:449–53.CrossRefPubMed
2.
Zurück zum Zitat Al-Ibraheem A, Al-Rasheed U, Mashhadani N, Abdlkadir AS, Al-Adhami DA, Ruzzeh S, et al. Long-Term Survival Analysis and Prognostic Factors of Arabic Patients with Differentiated Thyroid Carcinoma: A 20-Year Observational Study at the King Hussein Cancer Center (KHCC) Involving 528 Patients. Cancers. 2023;15:4102.CrossRefPubMedPubMedCentral Al-Ibraheem A, Al-Rasheed U, Mashhadani N, Abdlkadir AS, Al-Adhami DA, Ruzzeh S, et al. Long-Term Survival Analysis and Prognostic Factors of Arabic Patients with Differentiated Thyroid Carcinoma: A 20-Year Observational Study at the King Hussein Cancer Center (KHCC) Involving 528 Patients. Cancers. 2023;15:4102.CrossRefPubMedPubMedCentral
3.
Zurück zum Zitat Trybek T, Kowalska A. Does the presence of regional lymph node metastases have any impact on the complete remission rate in patients with distant metastases of papillary thyroid carcinoma (PTC), treated by radioiodine therapy? Endokrynol Pol. 2010;61:443–5.PubMed Trybek T, Kowalska A. Does the presence of regional lymph node metastases have any impact on the complete remission rate in patients with distant metastases of papillary thyroid carcinoma (PTC), treated by radioiodine therapy? Endokrynol Pol. 2010;61:443–5.PubMed
4.
Zurück zum Zitat Zhao H, Huang T, Li H. Risk factors for skip metastasis and lateral lymph node metastasis of papillary thyroid cancer. Surgery. 2019;166:55–60.CrossRefPubMed Zhao H, Huang T, Li H. Risk factors for skip metastasis and lateral lymph node metastasis of papillary thyroid cancer. Surgery. 2019;166:55–60.CrossRefPubMed
5.
Zurück zum Zitat Yildirim N, Dede DS, Gumuskaya B. FDG hepatic superscan due to metastatic infiltration of prostate cancer. Clin Nucl Med. 2020;45:474–6.CrossRefPubMed Yildirim N, Dede DS, Gumuskaya B. FDG hepatic superscan due to metastatic infiltration of prostate cancer. Clin Nucl Med. 2020;45:474–6.CrossRefPubMed
Metadaten
Titel
Hepatic Superscan in Medullary Thyroid Carcinoma: A Rare Presentation in [18F]FDG PET/CT
verfasst von
Ahmed Saad Abdlkadir
Dhuha Al-Adhami
Baraa Alsyouf
Raghad Alhouwari
Ula Al-Rasheed
Omar Jaber
Issa Mohamad
Akram Al-Ibraheem
Publikationsdatum
18.01.2024
Verlag
Springer Nature Singapore
Erschienen in
Nuclear Medicine and Molecular Imaging / Ausgabe 3/2024
Print ISSN: 1869-3474
Elektronische ISSN: 1869-3482
DOI
https://doi.org/10.1007/s13139-023-00836-z

Weitere Artikel der Ausgabe 3/2024

Nuclear Medicine and Molecular Imaging 3/2024 Zur Ausgabe